Debt to Capital Ratio: A measurement of a company's financial leverage, calculated as the company's long-term debt divided by its total capital. Calculated as: Total Long-Term Debt / (Total Long-Term Debt + Shareholders Equity)
Rigel Pharmaceuticals, Inc. (RIGL) had Debt to Capital Ratio of 0.20 for the most recently reported fiscal quarter, ending 2025-09-30.
| Income Statement Financials | |
$69.46M |
|
$27.90M |
|
$4.75M |
|
$64.71M |
|
$41.04M |
|
$28.42M |
|
$-0.80M |
|
$27.62M |
|
$27.62M |
|
$27.90M |
|
$27.90M |
|
$27.90M |
|
$27.90M |
|
$28.42M |
|
$28.56M |
|
18.04M |
|
19.16M |
|
$1.55 |
|
$1.46 |
|
| Balance Sheet Financials | |
$214.93M |
|
$0.05M |
|
$27.61M |
|
$242.53M |
|
$94.40M |
|
$29.97M |
|
$30.52M |
|
$124.92M |
|
$117.61M |
|
$92.27M |
|
$117.61M |
|
18.14M |
|
| Cash Flow Statement Financials | |
$53.67M |
|
$-67.00M |
|
$5.17M |
|
$56.75M |
|
$48.59M |
|
$-8.15M |
|
$9.96M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.28 |
|
-- |
|
-- |
|
|
Debt to Capital Ratio |
0.20 |
0.51 |
|
93.16% |
|
40.91% |
|
40.91% |
|
-- |
|
39.76% |
|
40.17% |
|
$53.66M |
|
-- |
|
-- |
|
-- |
|
0.29 |
|
0.36 |
|
1.51 |
|
59.50 |
|
23.72% |
|
30.24% |
|
11.50% |
|
18.91% |
|
$6.48 |
|
$2.80 |
|
$2.80 |
|